LY-293,284

LY-293284

Identifiers
IUPAC name (4R)-6-acetyl-4-(di-n-propylamino)-1,3,4,5-tetrahydrobenz[c,d]indole
CAS Number	141318-62-9 Y
PubChem CID	132345
IUPHAR/BPS	19
ChemSpider	116875
Chemical and physical data
Formula	C19H26N2O
Molar mass	298.423 g/mol
3D model (Jmol)	Interactive image
SMILES CCCN(CCC)[C@H]1CC2=CNC3=C2C(=C(C=C3)C(=O)C)C1
InChI InChI=1S/C19H26N2O/c1-4-8-21(9-5-2)15-10-14-12-20-18-7-6-16(13(3)22)17(11-15)19(14)18/h6-7,12,15,20H,4-5,8-11H2,1-3H3/t15-/m0/s1 Key:CKYZLYQSDNLGPT-HNNXBMFYSA-N

LY-293284 is a research chemical developed by the pharmaceutical company Eli Lilly and used for scientific studies. It acts as a potent and selective 5-HT_1A receptor full agonist. It was derived through structural simplification of the ergoline based psychedelic LSD, but is far more selective for 5-HT_1A with over 1000x selectivity over other serotonin receptor subtypes and other targets. It has anxiogenic effects in animal studies.